Daily Archives: January 9, 2023
We are back with our activities! Expect some changes in the alerts to better cover some specialties and subspecialties that have had fewer articles until now; also, expect a broader coverage of journals. If you enjoy our selection of articles, it would mean a lot to us if you sent our Telegram channels links to your friends (doctors or medical students). Happy 2023!
9 Jan, 2023 | 15:07h | UTCAll Channels (175 specialties and subspecialties)
https://www.linksmedicus.com/telegram-updates/
(You can follow any of the 175 channels just by clicking on the specialties and subspecialties in the link above.)
Public Telegram Channels
All Posts – https://t.me/medicine_linksmedicus
Cardiology – https://t.me/Cardiology_LinksMedicus
Covid-19 – https://t.me/Covid19_linksmedicus
Critical Care & Emergencies – https://t.me/CriticalCare_LinksMedicus
Evidence-Based Medicine – https://t.me/Evidence_Based_Medicine_LinksMed
Guidelines – https://t.me/Guidelines_LinksMedicus
Gynecology & Obstetrics – https://t.me/Gynecology_Obstetrics_LinksMedic
Internal Medicine – https://t.me/Internal_Medicine_LinksMedicus
Oncology – https://t.me/Oncology_LinksMedicus
Pediatrics – https://t.me/Pediatrics_LinksMedicus
(You can share any of these links directly.)
ACP Guideline | Pharmacologic treatment of primary osteoporosis or low bone mass to prevent fractures in adults
9 Jan, 2023 | 14:59h | UTCSummary for Patients: Pharmacologic Treatment of Primary Osteoporosis or Low Bone Mass to Prevent Fractures in Adults
WHO updates recommendations on HPV vaccination schedule
9 Jan, 2023 | 14:57h | UTCNews Release: WHO updates recommendations on HPV vaccination schedule – World Health Organization
Guideline: Human papillomavirus vaccines: WHO position paper, December 2022 – World Health Organization
Commentaries:
WHO supports 1-dose HPV vaccine strategy – CIDRAP
Commentary on Twitter
? WHO has revised its recommendations on possible schedules for human papillomavirus (#HPV) vaccines & now recommends:
?1 or 2-doses for girls & women aged 9-20
?2 doses with a 6-month interval for women 21+https://t.co/m0KZyH6sPR pic.twitter.com/W4PeS4raV9— World Health Organization (WHO) (@WHO) December 21, 2022
11 clinical trials that will shape medicine in 2023
9 Jan, 2023 | 14:54h | UTC11 clinical trials that will shape medicine in 2023 – Nature
WHO | Increase in invasive Group A streptococcal infections among children in Europe, including fatalities
9 Jan, 2023 | 14:53h | UTC
RCT | VV116 vs. Nirmatrelvir–Ritonavir for oral treatment of Covid-19
9 Jan, 2023 | 14:50h | UTCVV116 versus Nirmatrelvir–Ritonavir for Oral Treatment of Covid-19 – New England Journal of Medicine
Commentaries:
Study could pave way for new antiviral, as China grapples with Covid wave – STAT
Chinese oral COVID-19 drug equally effective with Paxlovid: study
VV116 Noninferior to Nirmatrelvir-Ritonavir for COVID-19 – HealthDay
Commentary on Twitter
In a Chinese trial involving participants with symptomatic mild-to-moderate Covid-19, VV116 (an oral analogue of remdesivir) was noninferior to nirmatrelvir–ritonavir with respect to the time to sustained clinical recovery.
Read the full study: https://t.co/zckTB3Rvb9 pic.twitter.com/0TVF7hEXjP
— NEJM (@NEJM) December 28, 2022
Guideline | Treatment of hypercalcemia of malignancy in adults
9 Jan, 2023 | 14:46h | UTCNews Release: Experts provide first framework for treating hypercalcemia of malignancy in adults – News Medical
The WHO estimates of excess mortality associated with the COVID-19 pandemic
9 Jan, 2023 | 14:48h | UTCThe WHO estimates of excess mortality associated with the COVID-19 pandemic – Nature
Commentary: Pandemic’s Two-Year Global Death Toll May Be Close to 15 Million – HealthDay
Scientists tie third clinical trial death to experimental Alzheimer’s drug
9 Jan, 2023 | 14:47h | UTCScientists tie third clinical trial death to experimental Alzheimer’s drug – Science
Related: RCT | Lecanemab slows cognitive decline in early Alzheimer’s disease but raises safety concerns.
ESC/AHA/ACC/WHF Joint Opinion | Randomized trials fit for the 21st century
9 Jan, 2023 | 14:44h | UTCCommentaries:
It’s Time to Revamp How Clinical Trials Are Done, Say Cardiology Societies – TCTMD
Commentary on Twitter
Together with @ACCinTouch @escardio & @worldheartfed, we are positioned to push, guide and support the remodeling of #RCTs for the 21st century. #RedesignRCTs
Read the joint statement in @circaha: https://t.co/hoypaSp10m pic.twitter.com/vwMGx0tksz
— AHA Science (@AHAScience) December 16, 2022
Consensus Guideline | Management of the perioperative patient on cannabis and cannabinoids
9 Jan, 2023 | 14:43h | UTC
Commentary on Twitter
All Patients Should be Screened for #Cannabis Use Before #Surgery, According to First U.S. Guidelines: https://t.co/QwAeh0cjFH @RAPMOnline @ShaliniShahMD @NarouzeMD @rakesh6282 @Drhaclarke @garyschwartzmd @ASALifeline pic.twitter.com/yPqaUauZMW
— ASRA Pain Medicine (@ASRA_Society) January 3, 2023
ASCO Guideline | Immunotherapy and targeted therapy for advanced gastroesophageal cancer
9 Jan, 2023 | 14:40h | UTC
ASCO Guideline | Immunotherapy and biomarker testing in recurrent and metastatic head and neck cancers
9 Jan, 2023 | 14:41h | UTCNews Release: ASCO Publishes New Guideline on Immunotherapy, Biomarker Testing in Advanced Head and Neck Cancer – ASCO Daily News
Cohort Study | Association of habitual checking behaviors on social media with longitudinal functional brain development
9 Jan, 2023 | 14:38h | UTCAssociation of Habitual Checking Behaviors on Social Media With Longitudinal Functional Brain Development – JAMA Pediatrics (link to abstract – $ for full-text)
Commentaries:
Social Media Checking Behaviors in Teens Linked to Brain Changes – HealthDay
For adolescents, social media might be a brain-changer, researchers say – CNN
M-A | Physical activity interventions to alleviate depressive symptoms in children and adolescents
9 Jan, 2023 | 14:37h | UTCPhysical Activity Interventions to Alleviate Depressive Symptoms in Children and Adolescents: A Systematic Review and Meta-analysis – JAMA Pediatrics (link to abstract – $ for full-text)
Commentary: Exercise, Sports: A Natural Antidepressant for Teens – HealthDay
Commentary on Twitter
The results of this systematic review and meta-analysis suggest that physical activity interventions can alleviate symptoms of depression in children and adolescents. https://t.co/7P6gWPf35K
— JAMA Pediatrics (@JAMAPediatrics) January 3, 2023
The year in cardiovascular medicine 2022: the top 10 papers in acute cardiac care and ischemic heart disease
9 Jan, 2023 | 14:28h | UTC
Commentary on Twitter
The Year in Cardiovascular Medicine 2022 series: the Top 10 papers in Cardiovascular Imaging https://t.co/OVJxxYu71p@escardio #EHJ #ESCYoung #cardiotwitter @ehj_ed @rladeiraslopes #CVD #cvimaging @chiarabd @NAjmoneMarsan pic.twitter.com/sooF0bz3LN
— European Society of Cardiology Journals (@ESC_Journals) January 2, 2023
The year in cardiovascular medicine 2022: the top 10 papers in dyslipidemias
9 Jan, 2023 | 14:26h | UTC
Commentary on Twitter
The Year in Cardiovascular Medicine 2022 series: the Top 10 papers in Dyslipidaemia https://t.co/jpkqgt4Hf1 @escardio #EHJ #ESCYoung #cardiotwitter @ehj_ed @rladeiraslopes #CVD #dyslipidemia pic.twitter.com/UBfKy45mAu
— European Society of Cardiology Journals (@ESC_Journals) January 2, 2023
The year in cardiovascular medicine 2022: the top 10 papers in heart failure and cardiomyopathies
9 Jan, 2023 | 14:10h | UTC
Commentary on Twitter
The Year in Cardiovascular Medicine 2022 series: the Top 10 papers in Heart Failure and Cardiomyopathies https://t.co/w6opcMPcBa@escardio #EHJ #ESCYoung #cardiotwitter @ehj_ed @rladeiraslopes #HeartFailure #Cardiomyopathies pic.twitter.com/UrrX2LUQdI
— European Society of Cardiology Journals (@ESC_Journals) January 2, 2023
The year in cardiovascular medicine 2022: the top 10 papers in cardiovascular imaging
9 Jan, 2023 | 14:21h | UTC
Commentary on Twitter
The Year in Cardiovascular Medicine 2022 series: the Top 10 papers in Acute Cardiac Care and Ischaemic Heart Disease https://t.co/nRNjEyAeDR@escardio #EHJ #ESCYoung #cardiotwitter @ehj_ed @rladeiraslopes #cvacute #ischaemic #heartdisease pic.twitter.com/qCoug19mNJ
— European Society of Cardiology Journals (@ESC_Journals) January 2, 2023
The year in cardiovascular medicine 2022: the top 10 papers in arrhythmias
9 Jan, 2023 | 14:19h | UTCThe year in cardiovascular medicine 2022: the top 10 papers in arrhythmias – European Heart Journal
Commentary on Twitter
The Year in Cardiovascular Medicine 2022 series: the Top 10 papers in Arrhythmias https://t.co/D3GM1l8TgW@escardio #EHJ #ESCYoung #cardiotwitter @ehj_ed @rladeiraslopes #CVD #arrhythmias pic.twitter.com/kxXqyEx8KM
— European Society of Cardiology Journals (@ESC_Journals) January 2, 2023
The year in cardiovascular medicine 2022: the top 10 papers in cardio-oncology
9 Jan, 2023 | 14:08h | UTC
Commentary on Twitter
The Year in Cardiovascular Medicine 2022 series: the Top 10 papers in Cardio-oncology https://t.co/hfWJ94MmxK@escardio #EHJ #ESCYoung #cardiotwitter @ehj_ed @rladeiraslopes @mayocvonc #cardioonco #CVD @TeresaLpezFdez1 pic.twitter.com/30SNvdvkEV
— European Society of Cardiology Journals (@ESC_Journals) January 2, 2023
Phase 1-2 study | Adagrasib with or without Cetuximab in colorectal cancer with mutated KRAS G12C
9 Jan, 2023 | 14:04h | UTCAdagrasib with or without Cetuximab in Colorectal Cancer with Mutated KRAS G12C – New England Journal of Medicine (link to abstract – $ for full-text)
News Release: Advanced Colorectal Cancer Treatment Targets KRAS Gene With Drug Combo – Memorial Sloan Kettering Cancer Center
Commentary on Twitter
In heavily pretreated patients with mutant KRAS G12C colorectal cancer, adagrasib induced a response in 19% as single agent and in 46% in combination with cetuximab, an epidermal growth factor receptor antibody. https://t.co/nCoEPeV9oB pic.twitter.com/FCHxU9WCin
— NEJM (@NEJM) December 21, 2022
Left heart catheterization complications | ED presentations, evaluation, and management
9 Jan, 2023 | 14:07h | UTCLeft Heart Catheterization Complications: ED Presentations, Evaluation, and Management – emDocs
Review | Transmission of Group B Streptococcus in late-onset neonatal disease
9 Jan, 2023 | 14:05h | UTC
M-A | Laparoscopic vs. open pancreatoduodenectomy in patients with periampullary tumors
9 Jan, 2023 | 14:02h | UTCLaparoscopic versus Open Pancreatoduodenectomy in Patients with Periampullary Tumors: A Systematic Review and Meta-analysis – Annals of Surgery (link to abstract – $ for full-text)